JP2023539463A5 - - Google Patents

Info

Publication number
JP2023539463A5
JP2023539463A5 JP2023512031A JP2023512031A JP2023539463A5 JP 2023539463 A5 JP2023539463 A5 JP 2023539463A5 JP 2023512031 A JP2023512031 A JP 2023512031A JP 2023512031 A JP2023512031 A JP 2023512031A JP 2023539463 A5 JP2023539463 A5 JP 2023539463A5
Authority
JP
Japan
Prior art keywords
monocyclic
group
alkyl
membered
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023512031A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023539463A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/045696 external-priority patent/WO2022040002A1/en
Publication of JP2023539463A publication Critical patent/JP2023539463A/ja
Publication of JP2023539463A5 publication Critical patent/JP2023539463A5/ja
Pending legal-status Critical Current

Links

JP2023512031A 2020-08-17 2021-08-12 Pd-l1を標的とするための方法及び組成物 Pending JP2023539463A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063066689P 2020-08-17 2020-08-17
US63/066,689 2020-08-17
US202163210423P 2021-06-14 2021-06-14
US63/210,423 2021-06-14
PCT/US2021/045696 WO2022040002A1 (en) 2020-08-17 2021-08-12 Methods and compositions for targeting pd-l1

Publications (2)

Publication Number Publication Date
JP2023539463A JP2023539463A (ja) 2023-09-14
JP2023539463A5 true JP2023539463A5 (enExample) 2024-08-19

Family

ID=80350607

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023512031A Pending JP2023539463A (ja) 2020-08-17 2021-08-12 Pd-l1を標的とするための方法及び組成物

Country Status (9)

Country Link
US (1) US11760761B2 (enExample)
EP (1) EP4185569B1 (enExample)
JP (1) JP2023539463A (enExample)
KR (1) KR20230059801A (enExample)
CN (1) CN116209663A (enExample)
AU (1) AU2021329259A1 (enExample)
CA (1) CA3190154A1 (enExample)
TW (1) TW202227451A (enExample)
WO (1) WO2022040002A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021275118A1 (en) 2020-05-22 2022-12-01 Aligos Therapeutics, Inc. Methods and compositions for targeting PD-L1
CN115232109A (zh) * 2021-04-25 2022-10-25 广东东阳光药业有限公司 Pd-1/pd-l1类小分子抑制剂及其在药物中的应用
MX2023014754A (es) 2021-06-18 2024-02-12 Aligos Therapeutics Inc Métodos y composiciones dirigidos a pd-l1.
WO2023283256A1 (en) 2021-07-09 2023-01-12 Aligos Therapeutics, Inc. Anti-viral compounds
US12065428B2 (en) 2021-09-17 2024-08-20 Aligos Therapeutics, Inc. Anti-viral compounds
CN119212987A (zh) 2021-12-16 2024-12-27 安力高医药股份有限公司 用于靶向pd-l1的方法和组合物
AU2023303408A1 (en) 2022-07-06 2024-12-19 Aligos Therapeutics, Inc. Anti-viral compounds
WO2024134466A1 (en) * 2022-12-21 2024-06-27 Arbutus Biopharma Corporation Substituted arylamine compounds, substituted heteroarylamine compounds, and methods using same
AU2024224371A1 (en) * 2023-02-23 2025-08-07 Sunshine Lake Pharma Co., Ltd. Pyridopyrimidine derivative and use thereof
WO2025015063A1 (en) * 2023-07-13 2025-01-16 Aligos Therapeutics, Inc. Methods and compositions for targeting pd-l1
WO2025171031A1 (en) * 2024-02-07 2025-08-14 Aligos Therapeutics, Inc. Pd-l1 compounds with a bicyclic group
WO2025171025A1 (en) * 2024-02-07 2025-08-14 Aligos Therapeutics, Inc. Pd-l1 compounds with a bicyclic group
WO2025174835A1 (en) * 2024-02-15 2025-08-21 Aligos Therapeutics, Inc. Methods and compositions for targeting pd-l1
WO2025199281A1 (en) * 2024-03-22 2025-09-25 Aligos Therapeutics, Inc. Methods and compositions for targeting pd-l1
WO2025199273A1 (en) * 2024-03-22 2025-09-25 Aligos Therapeutics, Inc. Methods and compositions for targeting pd-l1

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE180771T1 (de) 1989-07-17 1999-06-15 Dow Chemical Co Mesogene polycyanate und polycyanamide und ihre hitzegehärteten gegenstände
AU2002368274A1 (en) 2001-09-13 2004-06-03 Genesoft, Inc. Methods of treating infection by drug resistant bacteria
US6995144B2 (en) 2002-03-14 2006-02-07 Eisai Co., Ltd. Nitrogen containing heterocyclic compounds and medicines containing the same
US20080186971A1 (en) 2007-02-02 2008-08-07 Tarari, Inc. Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
FR2913883B1 (fr) 2007-03-20 2009-06-05 Oreal Utilisation pour la coloration des fibres keratiniques d'une composition comprenant un compose halochromique et/ou le colorant correspondant a ce compose
KR20100033981A (ko) 2007-06-03 2010-03-31 벤더르빌트 유니버시티 벤즈아미드 대사성 글루타민산염 수용체5 양성 알로스테릭 조절자 및 이의 제조 및 사용방법
WO2009036066A1 (en) 2007-09-10 2009-03-19 Curis, Inc. Vegfr inhibitors containing a zinc binding moiety
JP5219583B2 (ja) 2008-03-31 2013-06-26 住友化学株式会社 組成物、光学フィルムとその製造方法、光学部材及び表示装置
US8049411B2 (en) 2008-06-05 2011-11-01 Idemitsu Kosan Co., Ltd. Material for organic electroluminescence device and organic electroluminescence device using the same
CN102056911B (zh) 2008-06-05 2015-07-22 出光兴产株式会社 卤素化合物、多环系化合物及使用其的有机电致发光元件
JP5443720B2 (ja) 2008-09-05 2014-03-19 住友化学株式会社 組成物、光学フィルム及びその製造方法、光学部材ならびに表示装置
AU2010333338A1 (en) 2009-12-14 2012-08-02 Merck Patent Gmbh Sphingosine kinase inhibitors
PL2526093T3 (pl) 2010-01-22 2017-02-28 Acetylon Pharmaceuticals, Inc. Odwrócone związki amidowe jako inhibitory deacetylazy białkowej oraz sposoby ich stosowania
JP2012051874A (ja) 2010-07-28 2012-03-15 Sumitomo Chemical Co Ltd 縮合環化合物、有機薄膜及び有機薄膜素子
JP2012126876A (ja) 2010-11-24 2012-07-05 Sumitomo Chemical Co Ltd 共役系化合物、並びにこれを用いた有機薄膜及び有機薄膜素子
KR101848885B1 (ko) 2012-10-29 2018-04-16 삼성디스플레이 주식회사 아민계 화합물 및 이를 포함한 유기 발광 소자
KR102121582B1 (ko) 2012-12-12 2020-06-10 에스에프씨 주식회사 피렌계 화합물 및 이를 이용한 유기전계발광소자
US9458125B2 (en) 2012-12-17 2016-10-04 Jnc Corporation Octahydro binaphthyl-based chiral compound-containing liquid-crystal composition and optical element
KR102086547B1 (ko) 2013-02-13 2020-05-28 삼성디스플레이 주식회사 유기 발광 소자
KR20140140417A (ko) 2013-05-29 2014-12-09 삼성디스플레이 주식회사 유기 발광 소자
KR102098738B1 (ko) 2013-07-09 2020-06-01 삼성디스플레이 주식회사 유기 발광 소자
US9871205B2 (en) 2013-08-02 2018-01-16 Samsung Display Co., Ltd. Organic light-emitting device
KR102086556B1 (ko) 2013-08-02 2020-03-10 삼성디스플레이 주식회사 유기 발광 소자
KR20150035317A (ko) 2013-09-27 2015-04-06 삼성디스플레이 주식회사 유기 발광 소자
WO2015063046A1 (en) 2013-10-31 2015-05-07 Basf Se Azadibenzothiophenes for electronic applications
US10158083B2 (en) 2013-12-12 2018-12-18 Merck Patent Gmbh Materials for electronic devices
KR101670056B1 (ko) 2014-02-20 2016-10-28 삼성디스플레이 주식회사 유기 발광 소자
KR101806164B1 (ko) 2014-03-24 2017-12-07 주식회사 스킨앤스킨 신규한 유기발광화합물 및 이를 포함하는 유기 발광 소자
KR101735688B1 (ko) 2014-06-17 2017-05-15 주식회사 엘지화학 고리형 올레핀 화합물, 광반응성 중합체 및 이를 포함하는 배향막
CN106065009B (zh) 2014-06-28 2019-03-01 广东东阳光药业有限公司 作为丙型肝炎抑制剂的化合物及其在药物中的应用
KR101641023B1 (ko) 2014-08-27 2016-07-20 씨제이헬스케어 주식회사 신규한 아미노-페닐-설포닐-아세테이트 유도체 및 이의 용도
WO2016032120A1 (ko) 2014-08-27 2016-03-03 씨제이헬스케어 주식회사 신규한 아미노-페닐-설포닐-아세테이트 유도체 및 이의 용도
CN107075375B (zh) 2014-12-25 2020-11-13 Dic株式会社 向列液晶组合物及使用其的液晶显示元件
KR102384224B1 (ko) 2014-12-30 2022-04-08 삼성전자주식회사 축합환 화합물 및 이를 포함한 유기 발광 소자
KR101910112B1 (ko) 2015-05-06 2018-10-19 삼성에스디아이 주식회사 유기광전자소자용 도펀트, 유기광전자소자 및 표시장치
EP3294695B1 (en) * 2015-05-11 2020-09-30 Compact Membrane Systems, Inc. Thin film composite membranes for separation of alkenes from alkanes
KR102002034B1 (ko) 2015-07-09 2019-07-22 에스에프씨주식회사 고효율과 장수명을 갖는 유기 발광 소자
US10690952B2 (en) 2015-08-11 2020-06-23 Dic Corporation Liquid crystal display element
JP6808916B2 (ja) 2015-08-11 2021-01-06 Dic株式会社 液晶表示素子
CN107850810B (zh) 2015-08-11 2021-06-15 Dic株式会社 液晶显示元件
JP6949055B2 (ja) 2016-02-05 2021-10-13 ヴェラ ファーマシューティカルズ,エルエルシー 感染症を治療するための組成物および方法
KR102111149B1 (ko) 2016-11-11 2020-05-14 주식회사 엘지화학 유기 발광 소자
KR102044806B1 (ko) 2017-02-15 2019-11-15 기초과학연구원 신규한 화합물 및 이의 용도
BR102018007822A2 (pt) 2017-04-20 2018-11-06 Gilead Sciences, Inc. composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição
CN109265471B (zh) 2017-06-30 2021-06-04 轩竹生物科技有限公司 Fxr受体激动剂
KR102377225B1 (ko) 2017-07-13 2022-03-22 에스에프씨주식회사 고효율 및 장수명 특성을 가지는 유기 발광 소자
JP6801796B2 (ja) 2017-12-22 2020-12-16 Dic株式会社 重合性液晶組成物及び液晶表示素子ならびに重合性化合物
WO2019127008A1 (zh) 2017-12-26 2019-07-04 清华大学 一种靶向降解btk的化合物及其应用
WO2019160882A1 (en) * 2018-02-13 2019-08-22 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
KR102679423B1 (ko) 2018-03-13 2024-07-02 삼성디스플레이 주식회사 유기 발광 소자
CN116332914B (zh) 2018-03-29 2025-04-15 德山新勒克斯有限公司 用于有机电气元件的化合物、使用所述化合物的有机电气元件及其电子装置
KR102591947B1 (ko) * 2018-04-19 2023-10-25 길리애드 사이언시즈, 인코포레이티드 Pd-1/pd-l1 억제제
WO2019212290A1 (ko) 2018-05-04 2019-11-07 덕산네오룩스 주식회사 유기전기소자용 화합물, 이를 이용한 유기전기소자 및 그 전자 장치
WO2019226991A1 (en) 2018-05-25 2019-11-28 Essa Pharma, Inc. Androgen receptor modulators and methods for their use
KR102617841B1 (ko) 2018-05-29 2023-12-26 덕산네오룩스 주식회사 유기전기소자용 화합물, 이를 이용한 유기전기소자 및 그 전자 장치
CN110372693B (zh) 2018-07-04 2022-05-03 清华大学 一种靶向降解bet蛋白的化合物及其应用
WO2020006724A1 (zh) 2018-07-05 2020-01-09 清华大学 一种靶向降解fak蛋白的化合物及其应用
CN108794453A (zh) 2018-07-05 2018-11-13 清华大学 一种靶向降解fak蛋白的化合物及其应用
PE20210642A1 (es) * 2018-07-13 2021-03-23 Gilead Sciences Inc Inhibidores de pd-1/pd-l1
AU2019364417A1 (en) 2018-10-24 2021-05-20 Araxes Pharma Llc 2-(2-acryloyl-2,6-diazaspiro[3.4]octan-6-yl)-6-(1H-indazol-4-yl)-benzonitrile derivatives and related compounds as inhibitors of G12C mutant KRAS protein for inhibiting tumor metastasis
CN111423422A (zh) 2019-01-09 2020-07-17 苏州泽璟生物制药股份有限公司 芳基酰胺类抑制剂及其制备方法和应用
EP4100381A4 (en) 2020-02-03 2024-04-03 Arbutus Biopharma Corporation SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS OF USE THEREOF
AU2021275118A1 (en) 2020-05-22 2022-12-01 Aligos Therapeutics, Inc. Methods and compositions for targeting PD-L1
MX2023014754A (es) 2021-06-18 2024-02-12 Aligos Therapeutics Inc Métodos y composiciones dirigidos a pd-l1.

Similar Documents

Publication Publication Date Title
JP2005537248A5 (enExample)
JP2016500107A5 (ja) グルタミナーゼ阻害剤およびその使用方法
JP2001526269A5 (enExample)
JP2016518437A5 (enExample)
JP2018510139A5 (enExample)
JP2018127459A5 (enExample)
JP2015505296A5 (enExample)
JP2013521312A5 (enExample)
JP2005523922A5 (enExample)
JP2020506951A5 (enExample)
RU2010101212A (ru) Бром-фенил замещенные тиазолилдигидропиримидины
JP2012507522A5 (enExample)
JP2011513410A5 (enExample)
JP2014518543A5 (enExample)
JP2001526218A5 (enExample)
JPWO2023195529A5 (enExample)
JP2020532545A5 (enExample)
JP2005511545A5 (enExample)
JP2003503449A5 (enExample)
JP2019520344A5 (enExample)
JP2023527961A5 (enExample)
JP2005529965A5 (enExample)
JP2005511594A5 (enExample)
JP2004525905A5 (enExample)
JP2015504917A5 (enExample)